UY26404A1 - METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE - Google Patents

METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE

Info

Publication number
UY26404A1
UY26404A1 UY26404A UY26404A UY26404A1 UY 26404 A1 UY26404 A1 UY 26404A1 UY 26404 A UY26404 A UY 26404A UY 26404 A UY26404 A UY 26404A UY 26404 A1 UY26404 A1 UY 26404A1
Authority
UY
Uruguay
Prior art keywords
phosphodiesterase
methods
polynucleotides
polypeptides
cyclic nucleotide
Prior art date
Application number
UY26404A
Other languages
Spanish (es)
Inventor
Kapeller Libermann Rosana
Hunter John Joseph
Williamson Mark
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Priority to UY26404A priority Critical patent/UY26404A1/en
Publication of UY26404A1 publication Critical patent/UY26404A1/en

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

Métodos para usar una fosfodiesterasa humana de nucleótidos cíclicos de la superfamilia de las fosfodiesterasas de mamíferos. Métodos para usar los polinucleótidos que codifican la fosfodiesterasa. Métodos para usar los polipéptidos y polinucleótidos de la fosfodiesterasa como blanco para diagnosis y tratamiento de afecciones mediadas o relacionadas con la fosfodiesterasa. Métodos para el análisis de drogas que usan los polipéptidos y los polinucleótidos de la fosfodiesterasa para identificar agonistas y antagonistas para diagnosis y tratamientos. Agonistas y antagonistas basados en los polipéptidos y polinucleótidos de la fosfodiesterasa. Agonistas y antagonistas identificados por medio de los métodos de análisis de drogas con los polipéptidos y los polinuclótidos de la fosfodiesterasa como blanco.Methods for using a human cyclic nucleotide phosphodiesterase from the mammalian phosphodiesterase superfamily. Methods for using polynucleotides encoding phosphodiesterase. Methods for using phosphodiesterase polypeptides and polynucleotides as a target for diagnosis and treatment of phosphodiesterase-related or mediated conditions. Drug testing methods that use phosphodiesterase polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. Agonists and antagonists based on phosphodiesterase polypeptides and polynucleotides. Agonists and antagonists identified by drug analysis methods with phosphodiesterase polypeptides and polynucleotides targeted.

UY26404A 2000-10-18 2000-10-18 METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE UY26404A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY26404A UY26404A1 (en) 2000-10-18 2000-10-18 METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY26404A UY26404A1 (en) 2000-10-18 2000-10-18 METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE

Publications (1)

Publication Number Publication Date
UY26404A1 true UY26404A1 (en) 2001-06-29

Family

ID=38812267

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26404A UY26404A1 (en) 2000-10-18 2000-10-18 METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE

Country Status (1)

Country Link
UY (1) UY26404A1 (en)

Similar Documents

Publication Publication Date Title
NI200700158A (en) GLP-1 AGONISTS, COMPOSITIONS, METHODS AND USES
Mathy et al. Synaptically induced long-term modulation of electrical coupling in the inferior olive
CR11042A (en) ANTIBODIES OX40 ANTAGONISTS AND ITS USE IN THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES
AR051524A1 (en) PATIENT SELECTION FOR A THERAPY WITH A HER INHIBITOR
CO6362020A2 (en) MUTANTS FGF21 AND USE OF THE SAME
ECSP077985A (en) PROTEIN CINASE INHIBITORS DERIVED FROM PIRROL (2,3-B) PIRIDINE
ES2572372T3 (en) Diagnostic method of neurodegenerative diseases based on the measurement of levels or activity of SIRT1
AR062709A1 (en) ANTAGONISTS OF THE WNT GEN AND ITS USE IN THE DIAGNOSIS AND TREATMENT OF DISORDERS MEDIATED BY THE WNT
AR030236A1 (en) MOLECULES SIMILAR TO IL-17 AND USES OF THE SAME
BRPI0413563A (en) compounds and compositions as inhibitors of tyrosine kinase receptor activity
UY30779A1 (en) USED DIHYDROPIRIDINE DERIVATIVES AS INHIBITORS OF PROTEIN QUINASE
AR084373A1 (en) COMPOSITIONS AND METHODS FOR THE ELIMINATION OF BIOPELLICLES
DE602008006748D1 (en) PORTABLE MEDICAL DEVICE WITH SAMPLE DETERGENT, DETERGENT AND INJECTION AGENT
DOP2010000076A (en) IMPROVED DETECTION OF MAGE-A EXPRESSION
CR11562A (en) BIS-PIRIDILPIRIDONAS AS ANTAGONISTS OF THE RECEIVER 1 OF THE CONCENTRATING HORMONE OF MELANINA
BR112015011723A2 (en) screening for tuberculosis using cpd data
ATE555814T1 (en) RADIOACTIVE AGENTS FOR IN VIVO PET IMAGING OF CCR5
PE20211304A1 (en) THERAPEUTIC AND DIAGNOSTIC METHODS FOR INFLAMMATORY DISEASES MEDIATED BY MASTOCYTES
UY32556A (en) DERIVATIVES OF QUINAZOLINADIONA, ITS PREPARATION AND ITS VARIOUS THERAPEUTIC APPLICATIONS
DOP2000000081A (en) METHODS TO USE 22045, A HUMAN PHOSPHODYSTERASE OF CYCLIC NUCLOSIDS
DK1949903T3 (en) Selective A2A receptor antagonists for the treatment of atrial fibrillation
PE20180577A1 (en) USE OF THE IL-3, IL-33 AND IL-12p40 MOLECULAR MARKERS TO CHARACTERIZE THE SEVERITY OF RESPIRATORY INFECTIONS BY RESPIRATORY SYNCITIAL VIRUS AND HUMAN METAPNEUMOVIRUS
AR029581A1 (en) METHODS FOR THE IDENTIFICATION OF COMBINATIONS OF ENTITIES AS THERAPEUTIC AGENTS
UY26404A1 (en) METHODS FOR USING A HUMAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE
BR112021009441A2 (en) Multiplexing highly evolving viral variants with Sherlock

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20121121